Zydus' Ambernath API Plant Clears USFDA Inspection with Zero Observations
USFDA successfully completes inspection at JB Chemicals and Pharma Gujarat facility
Ahmedabad: Zydus Lifesciences Limited has announced the successful completion of a USFDA surveillance inspection at its Active Pharmaceutical Ingredient (API) manufacturing facility in Ambernath, Maharashtra.
The inspection, conducted from February 10 to 14, 2025, concluded with zero observations, reflecting the company’s adherence to stringent regulatory and quality standards.
Also Read: Zydus, Synthon Ink Pact For New Oncology Product
In a regulatory filing with BSE Limited and NSE, Zydus Lifesciences stated that this outcome reinforces its commitment to maintaining high compliance standards in its manufacturing operations. The company disclosed the development under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The closure of the inspection without any adverse remarks from the U.S. Food and Drug Administration (USFDA) is a positive development for Zydus, as compliance with global regulatory agencies plays a crucial role in its API manufacturing and exports.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.